Looks like you’re on the UK site. Choose another location to see content specific to your location
Promega has launched its Spectrum Compact CE System
Promega has launched the Spectrum Compact CE System, its benchtop capillary electrophoresis (CE) instrument, which was established in collaboration with Hitachi High-Tech. The CE system is an integrated instrument for examining DNA that allows life scientists, in laboratories, to perform fragment analysis and Sanger sequencing and at the bench.
The Spectrum Compact CE System has many features, including a simple to use interface, on-site installation and operational training, suitable benchtop size, separate plug and play consumables and flexible run scheduling.
The instrument supports applications, including mixed sample analysis, microsatellite instability analysis, cell line authentication and forensic STR analysis. Furthermore, it can be controlled by either additional software that permits access from any registered computer on the same network or the integrated touchscreen and can process up to thirty-two samples in a single run. Regardless of the degree of expertise, the software brings CE capabilities to the hands of any scientist.
Also, Promega assists laboratories that incorporate the system into their workplace, including operational training and instrument and software installation on-site.
Doug Storts, Promega Head of Research, stated: “The Spectrum Compact CE is personal and that’s one of the huge advantages that scientists will see with this instrument. An individual can walk into the laboratory and with minimal training, be able to change all the consumables, select which chemistries they want to use for both DNA sequencing as well as for fragment analysis and perform the experiment. Literally everybody has access. It democratizes the use of the instrument in the laboratory.”
We have hundreds of jobs available across the Healthcare industry, find your perfect one now.
Stay informed
Receive the latest industry news, Tips and straight to your inbox.
- Share Article
- Share on Twitter
- Share on Facebook
- Share on LinkedIn
- Copy link Copied to clipboard